IMARC Group, a leading market research company, has recently releases report titled “Prostate Cancer Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global prostate cancer treatment market share, size and  forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How Big is the Prostate Cancer Treatment Market?

The global prostate cancer treatment market size reached US$ 7.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.

What is Prostate Cancer?

Prostate cancer is a severe malignant tumor caused by the uncontrollable division and growth of different abnormal cells in the prostate gland present in men. It is associated with erectile dysfunction, decreased force in the urine stream, blood in the urine and semen, bone pain, and losing weight. It can be treated via the usage of several therapeutics, including vaccines, medications, and surgeries. Prostate cancer treatment involves eliminating the prostate gland, surrounding tissue, and lymph nodes. It is provided to the patient according to the age, previous health history, and severity of the symptoms.

Request Free Sample Copy of This Report: https://www.imarcgroup.com/prostate-cancer-treatment-market/requestsample

What are the growth prospects and trends in the prostate cancer treatment industry?

 

The surging cases of prostate cancer, especially among the aging population, represent one of the primary factors driving the demand for prostate cancer treatment around the world. 

Moreover, the rising awareness among individuals about patient assistance programs (PAPs) by governments of numerous countries is favoring the growth of the market. In addition, the growing implementation of health insurance policies that provide financial assistance for prostate cancer treatment and reduce medical expenditure is influencing the market positively. 

Apart from this, the increasing awareness about prostate cancer, its symptoms, diagnosis, and the easy availability of the treatment options is propelling the growth of the market.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Drug Type:
•    Chemotherapy
•    Biological Therapy
•    Hormone Therapy
•    Others

Breakup by Distribution Channel:
•    Hospitals Pharmacies
•    Drug Stores and Retail Pharmacies
•    Online Pharmacies

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

Astellas Pharma Inc., AstraZeneca plc, Bayer Aktiengesellschaft, Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.), F. Hoffmann-La Roche AG, Ferring B.V., GlaxoSmithKline Plc, Ipsen (Mayroy SA), Novartis International AG, Takeda Pharmaceutical Company Ltd. and Tolmar Pharmaceuticals Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/